Sridhar
Venkatesh,
General Manager and President
(Corporation)
Learn more...
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ritu Banerjee,
Assistant Deputy Minister
| Director General's Office
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Government Procurement,
Health,
Budget,
Economic Development
Communication date:
2025-01-13
Posted date:
2025-02-15
Communication number:
5088-628541
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ritu Banerjee,
Assistant Deputy Minister
| Director General's Office
|
Innovation, Science and Economic Development Canada (ISED)
-
Kasondra White,
Director
| Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2024-12-09
Posted date:
2025-01-15
Communication number:
5088-625161
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Laurel Chester,
Sr Advisor
| Minister of Innovation, Science and Industry
|
Innovation, Science and Economic Development Canada (ISED)
-
Philip Jennings,
Deputy Minister
|
Innovation, Science and Economic Development Canada (ISED)
-
François-Philippe Champagne,
Minister
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Research and Development,
Economic Development
Communication date:
2024-11-29
Posted date:
2024-12-16
Communication number:
5088-624281
(amended from
5088-624278)
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Erin Henry,
Director General
| Centre for Immunization Programs
|
Public Health Agency of Canada (PHAC)
-
Jacqueline Kosche,
Director, Vaccine Logistics and Operations
|
Public Health Agency of Canada (PHAC)
-
Natalie Gravelle,
A/ Director
| Centre for Immunization Programs
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2024-11-27
Posted date:
2024-12-16
Communication number:
5088-625162
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Mohamed-Iqbal Ravalia,
Senator
|
Senate of Canada
Subject Matter of the communication:
Government Procurement,
Health,
Budget,
Economic Development
Communication date:
2024-11-27
Posted date:
2024-12-16
Communication number:
5088-624050
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Amanda Ratz,
Senior Advisor
| Deputy Minister's Office
|
Health Canada (HC)
-
Jill Norman ,
Director
| Centre for Communicable Diseases and Infection Control
|
Health Canada (HC)
-
Greg Orencsak,
Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Government Procurement,
Health,
Immigration,
Budget,
Economic Development
Communication date:
2024-11-26
Posted date:
2024-12-16
Communication number:
5088-623995
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Eshan Naik,
Director of Policy
| Minister's office
|
Health Canada (HC)
-
Mark Holland,
Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Government Procurement,
Health,
Budget,
Economic Development
Communication date:
2024-11-26
Posted date:
2024-12-16
Communication number:
5088-623994
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jean-Yves Duclos,
Member of Parliament
|
House of Commons
-
Loic Pare,
Regional Affairs Advisor
|
Public Services and Procurement Canada (PSPC)
Subject Matter of the communication:
Government Procurement,
Health
Communication date:
2024-11-22
Posted date:
2024-12-16
Communication number:
5088-623913
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ritu Banerjee,
Assistant Deputy Minister
| Director General's Office
|
Innovation, Science and Economic Development Canada (ISED)
-
Heather Earle,
Manager
| Life Sciences and Biomanufacturing Branch
|
Innovation, Science and Economic Development Canada (ISED)
-
Bryan Dalphy,
Deputy Director
| Life Sciences and Biomanufacturing Branch
|
Innovation, Science and Economic Development Canada (ISED)
-
Kasondra White,
Director
| Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
-
Simon Young,
Senior Policy Analyst
| Life Sciences and Biomanufacturing Branch
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health
Communication date:
2024-11-05
Posted date:
2024-12-16
Communication number:
5088-620076
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jacqueline Arthur,
Director, innovative Supply Solutions: AMR, CVTR
|
Public Health Agency of Canada (PHAC)
-
Niyi Lawuyi,
Manager of Supply Access and Logistics
|
Public Health Agency of Canada (PHAC)
-
Christina Surujballi ,
Senior Policy Analyst
|
Public Health Agency of Canada (PHAC)
-
Bronwen Clark-Brewin,
Policy Analyst
|
Public Health Agency of Canada (PHAC)
-
Joshua Atkinson,
Project Manager
|
Public Health Agency of Canada (PHAC)
-
Dylan Kovacs,
Policy analyst
|
Public Health Agency of Canada (PHAC)
-
Nesreen Mandanas,
Policy Analyst
|
Public Health Agency of Canada (PHAC)
-
Kathleen Dunn,
Senior advisor
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Government Procurement,
Health,
Budget,
Economic Development
Communication date:
2024-10-24
Posted date:
2024-11-15
Communication number:
5088-619025
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Melissa Sutherland,
A/ Director General
| Pandemic Preparation Coordination Office
|
Health Canada (HC)
-
Michelle Boudreau ,
Executive Director
| Strategic Policy Branch
|
Health Canada (HC)
-
Greg Orencsak,
Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2024-10-15
Posted date:
2024-11-15
Communication number:
5088-618560
(amended from
5088-618559)
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health
Communication date:
2024-10-01
Posted date:
2024-11-15
Communication number:
5088-615888
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Bryan Dalphy,
Deputy Director
| Life Sciences and Biomanufacturing Branch
|
Innovation, Science and Economic Development Canada (ISED)
-
Kasondra White,
Director
| Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
-
Ritu Banerjee,
Assistant Deputy Minister
| Director General's Office
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2024-09-26
Posted date:
2024-10-15
Communication number:
5088-615565
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Shuvaloy Majumdar,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2024-09-24
Posted date:
2024-10-15
Communication number:
5088-615452
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Mohamed-Iqbal Ravalia,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health
Communication date:
2024-09-24
Posted date:
2024-10-15
Communication number:
5088-615418
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Yasir Naqvi,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2024-09-23
Posted date:
2024-10-15
Communication number:
5088-615378
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Greg Orencsak ,
Deputy Minister
|
Health Canada (HC)
-
Eric Costen,
Associate Deputy Minister
| Office of the Associate Deputy Minister
|
Health Canada (HC)
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Joel Denis,
Director General
| Centre for Vaccine and Therapeutics Readiness
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health,
Research and Development,
Economic Development
Communication date:
2024-09-19
Posted date:
2024-10-15
Communication number:
5088-615344
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Pamela Aung-Thin,
Assistant Deputy Minister
| Health Products and Food Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2024-09-10
Posted date:
2024-10-15
Communication number:
5088-614511
View monthly communication report
